Company
Tsumura & Co.
Headquarters: Tokyo, Japan
Employees: 3,830
CEO: Mr. Terukazu Kato
Market Cap
¥202.48 Billion
JPY as of July 1, 2023
US$1.40 Billion
Top Competitors by Market Capitalization
Industry: Drug Manufacturers—Specialty & Generic
| Company | Market Cap (USD) |
|---|---|
Zoetis Inc.
|
$78.54 B |
MERCK Kommanditgesellschaft auf Aktien
|
$70.69 B |
Takeda Pharmaceutical Company Limited
|
$46.59 B |
Haleon plc
|
$37.99 B |
|
Eisai Co. Ltd
|
$17.26 B |
Sector:
| Company | Market Cap (USD) |
|---|---|
|
UnitedHealth Group
|
$428.70 B |
|
Lilly
|
$417.05 B |
|
Johnson & Johnson
|
$412.24 B |
Novo Nordisk
|
$329.83 B |
|
Merck
|
$275.82 B |
Detailed Description
Tsumura & Co. engages in the manufacture and sale of pharmaceutical products worldwide. The company offers Kampo extract intermediates and granular Kampo formulations. It is involved in the procurement, selection and processing, and storage of raw material crude drugs and crude drug pieces for decoction; manufacture of Kampo powdered extracts and traditional Chinese medicines, as well as Kampo powdered extracts; and sale of pharmaceuticals and food products. The company was founded in 1893 and is headquartered in Tokyo, Japan.
Stocks & Indices
Tsumura & Co. has the following listings and related stock indices.
Stock: JPX: 4540